BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 29968201)

  • 21. Image-guided Cryoablation for Sporadic Renal Cell Carcinoma: Three- and 5-year Outcomes in 220 Patients with Biopsy-proven Renal Cell Carcinoma.
    Breen DJ; King AJ; Patel N; Lockyer R; Hayes M
    Radiology; 2018 Nov; 289(2):554-561. PubMed ID: 30084744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma.
    Wang C; Wang H; Yang W; Hu K; Xie H; Hu KQ; Bai W; Dong Z; Lu Y; Zeng Z; Lou M; Wang H; Gao X; Chang X; An L; Qu J; Li J; Yang Y
    Hepatology; 2015 May; 61(5):1579-90. PubMed ID: 25284802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term Clinical Outcomes Following Radiofrequency and Microwave Ablation of Renal Cell Carcinoma at a Single VA Medical Center.
    Abboud SE; Patel T; Soriano S; Giesler J; Alvarado N; Kang P
    Curr Probl Diagn Radiol; 2018; 47(2):98-102. PubMed ID: 28648469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact on renal function of percutaneous thermal ablation of renal masses in patients with preexisting chronic kidney disease.
    Wehrenberg-Klee E; Clark TW; Malkowicz SB; Soulen MC; Wein AJ; Mondschein JI; Van Arsdalen K; Guzzo TJ; Stavropoulos SW
    J Vasc Interv Radiol; 2012 Jan; 23(1):41-5. PubMed ID: 22019179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous Cryoablation of Solitary, Sporadic Renal Cell Carcinoma: Outcome Analysis Based on Clear-Cell versus Papillary Subtypes.
    Haddad MM; Schmit GD; Kurup AN; Schmitz JJ; Boorjian SA; Geske J; Thompson RH; Callstrom MR; Atwell TD
    J Vasc Interv Radiol; 2018 Aug; 29(8):1122-1126. PubMed ID: 29887184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous biopsy and radiofrequency ablation of T1a renal cell carcinoma.
    Iguchi T; Hiraki T; Tomita K; Gobara H; Fujiwara H; Sakurai J; Matsui Y; Kanazawa S
    Diagn Interv Imaging; 2016 Nov; 97(11):1159-1164. PubMed ID: 27256108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
    Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
    Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term outcomes in healthy adults after radiofrequency ablation of T1a renal tumours.
    Ma Y; Bedir S; Cadeddu JA; Gahan JC
    BJU Int; 2014 Jan; 113(1):51-5. PubMed ID: 24053553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laparoscopic radiofrequency ablation of small renal tumors: long-term oncologic outcomes.
    Ramirez D; Ma YB; Bedir S; Antonelli JA; Cadeddu JA; Gahan JC
    J Endourol; 2014 Mar; 28(3):330-4. PubMed ID: 24156661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years.
    Tracy CR; Raman JD; Donnally C; Trimmer CK; Cadeddu JA
    Cancer; 2010 Jul; 116(13):3135-42. PubMed ID: 20564644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous CT- and MRI-guided Cryoablation of cT1 Renal Cell Carcinoma: Intermediate- to Long-term Outcomes in 307 Patients.
    Bhagavatula SK; Tuncali K; Shyn PB; Levesque VM; Chang SL; Silverman SG
    Radiology; 2020 Sep; 296(3):687-695. PubMed ID: 32633677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous Cryoablation of Stage T1b Renal Cell Carcinoma: Safety, Technical Results, and Clinical Outcomes.
    Gunn AJ; Joe WB; Salei A; El Khudari H; Mahmoud KH; Bready E; Keasler EM; Patten PP; Gordetsky JB; Rais-Bahrami S; Abdel Aal AK
    Cardiovasc Intervent Radiol; 2019 Jul; 42(7):970-978. PubMed ID: 31044292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The contemporary role of ablative treatment approaches in the management of renal cell carcinoma (RCC): focus on radiofrequency ablation (RFA), high-intensity focused ultrasound (HIFU), and cryoablation.
    Klatte T; Kroeger N; Zimmermann U; Burchardt M; Belldegrun AS; Pantuck AJ
    World J Urol; 2014 Jun; 32(3):597-605. PubMed ID: 24700308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas.
    McClure TD; Chow DS; Tan N; Sayre JA; Pantuck AJ; Raman SS
    J Vasc Interv Radiol; 2014 Nov; 25(11):1682-8; quiz 1689. PubMed ID: 25081202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of RFA versus MWA for T1a renal cell carcinoma: a propensity score analysis.
    Aarts BM; Gomez FM; Lopez-Yurda M; Bevers RFM; Herndriks J; Beets-Tan RGH; Bex A; Klompenhouwer EG; van der Meer RW
    Eur Radiol; 2023 Feb; 33(2):1040-1049. PubMed ID: 36066733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous Cryoablation of Renal Cell Carcinoma with Sinus Vein Involvement Based on Preprocedural Imaging.
    Atwell TD; Kurup AN; Boorjian SA; Schmitz JJ; Thompson RH; Leibovich BC; Schmit GD
    J Vasc Interv Radiol; 2017 Dec; 28(12):1651-1657. PubMed ID: 29042169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cryoablation of renal cell carcinoma for patients with stage 4 or 5 non-dialysis chronic kidney disease.
    Gobara H; Nakatsuka A; Shimizu K; Yamanaka T; Matsui Y; Iguchi T; Hiraki T; Yamakado K
    Jpn J Radiol; 2019 Jun; 37(6):481-486. PubMed ID: 30941617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of tumor histology and grade on treatment success of percutaneous renal cryoablation.
    Beksac AT; Rivera-Sanfeliz G; Dufour CA; Nseyo U; Hamilton Z; Berquist SW; Hassan AE; Raheem OA; Wang S; Wake RW; Gold RE; Derweesh IH
    World J Urol; 2017 Apr; 35(4):633-640. PubMed ID: 27484204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical evaluation of a novel bipolar radiofrequency ablation system for renal masses.
    Okhunov Z; Roy O; Duty B; Waingankar N; Herati A; Morgenstern N; Sheikh-Fayyaz S; Kavoussi LR
    BJU Int; 2012 Sep; 110(5):688-91. PubMed ID: 22394594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
    Zhou W; Uppot RN; Feldman AS; Arellano RS
    AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.